anagrelide

Generic: anagrelide

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name anagrelide
Generic Name anagrelide
Labeler chartwell rx, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

anagrelide hydrochloride anhydrous 1 mg/1

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-313
Product ID 62135-313_13156e50-28d1-0994-e063-6394a90a16ec
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA076683
Listing Expiration 2026-12-31
Marketing Start 2005-04-18

Pharmacologic Class

Classes
decreased platelet production [pe] phosphodiesterase 3 inhibitors [moa] platelet-reducing agent [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135313
Hyphenated Format 62135-313

Supplemental Identifiers

RxCUI
597850 597852
UPC
0362135312121 0362135313609
UNII
VNS4435G39

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name anagrelide (source: ndc)
Generic Name anagrelide (source: ndc)
Application Number ANDA076683 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1 mg/1
source: ndc
Packaging
  • 60 CAPSULE in 1 BOTTLE (62135-313-60)
source: ndc

Packages (1)

62135-313-60 60 CAPSULE in 1 BOTTLE (62135-313-60)

Ingredients (1)

anagrelide hydrochloride anhydrous (1 mg/1)

Linked Drug Pages (1)

Anagrelide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "13156e50-28d1-0994-e063-6394a90a16ec", "openfda": {"upc": ["0362135312121", "0362135313609"], "unii": ["VNS4435G39"], "rxcui": ["597850", "597852"], "spl_set_id": ["e031dfb3-56e1-4fea-95f2-c2936e2057a0"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (62135-313-60)", "package_ndc": "62135-313-60", "marketing_start_date": "20240205"}], "brand_name": "Anagrelide", "product_id": "62135-313_13156e50-28d1-0994-e063-6394a90a16ec", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Platelet Production [PE]", "Phosphodiesterase 3 Inhibitors [MoA]", "Platelet-reducing Agent [EPC]"], "product_ndc": "62135-313", "generic_name": "Anagrelide", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Anagrelide", "active_ingredients": [{"name": "ANAGRELIDE HYDROCHLORIDE ANHYDROUS", "strength": "1 mg/1"}], "application_number": "ANDA076683", "marketing_category": "ANDA", "marketing_start_date": "20050418", "listing_expiration_date": "20261231"}